Anatomical Shoulder Domelock System Study
← catalyst calendarNCT03312465 · readout in 2,304 d
Sponsored by Zimmer Biomet (industry) · ZBH — their whole pipeline →.
Phase
—
Status
Active, not recruiting
Study type
Observational
Enrollment
73actual
Sites
6
Countries
Belgium, Germany, Switzerland +1
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2017-09-28 | actual | When the study began enrolling |
| Primary completion | 2032-12-09 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2032-12-09 | estimated | The whole study's end, after follow-up |
| First posted | 2017-10-17 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-03-25 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Avascular Necrosis
- Revision Surgery
- Conditions Consequent to Earlier Operations
- Arthritis, Rheumatoid
- Arthritis, Degenerative
- Arthritis;Traumatic
Intervention
- Device: AS Domelock System
Primary outcome
what the primary-completion date above is the date OFImplant Survivorship
measured 10 Years
Permalink · ZBH's whole pipeline · Catalyst calendar · Every registered study · What changed